Scholars Central

Conference abstractPublished 12 Sep 2016

TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo

Authors: Ryang Hwa Lee

Texas A&M Health Science Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Human mesenchymal stem/progenitor cells (hMSCs) from bone marrow and other tissues are currently being administered to large numbers of patients. The trials are proceeding even though cultures of the cells are heterogeneous, and there is large variability among preparations of hMSCs due to differences among donors, culture conditions, and inconsistent tissue sampling. This is also confounded by the lack of definitive biomarkers to predict the efficacy of hMSCs in vivo. Therefore, the value of the data obtained from current clinical trials could be compromised by variations in the quality of the hMSCs employed. To ensure such trials continue generating quality data, there is a critical need for simple in vitro bioassays to predict hMSC efficacy in vivo. This presentation will provide the first biomarker that can predict the efficacy of hMSCs in suppressing sterile inflammation in vivo.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Tissue Science and Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “Ryang Hwa Lee”